Isabelle Ginon
Overview
Explore the profile of Isabelle Ginon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
206
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Revuz S, Decullier E, Ginon I, Lamblin N, Hatron P, Kaminsky P, et al.
PLoS One
. 2017 Oct;
12(10):e0184227.
PMID: 28981519
Background: Different pulmonary hypertension (PH) mechanisms are associated with hereditary haemorrhagic telangiectasia (HHT). Methods And Results: We conducted a retrospective study of all suspected cases of PH (echocardiographically estimated systolic...
2.
Azzopardi N, Dupuis-Girod S, Ternant D, Fargeton A, Ginon I, Faure F, et al.
MAbs
. 2015 Mar;
7(3):630-7.
PMID: 25751241
Hereditary hemorrhagic telangiectasia (HHT), a genetic vascular disorder associated with epistaxis and hepatic shunts, is responsible for high-output cardiac failure in rare cases. Bevacizumab, which targets vascular endothelial growth factor,...
3.
Ginon I, Decullier E, Finet G, Cordier J, Marion D, Saurin J, et al.
Eur J Intern Med
. 2013 Jan;
24(3):e35-9.
PMID: 23312966
Background: HHT patients with liver vascular malformations (VMs) may develop high-output cardiac failure requiring liver transplant in few cases. Objective: Our aim is to show that echocardiography is a good...
4.
Dupuis-Girod S, Ginon I, Saurin J, Marion D, Guillot E, Decullier E, et al.
JAMA
. 2012 Mar;
307(9):948-55.
PMID: 22396517
Context: The only treatment available to restore normal cardiac output in patients with hereditary hemorrhagic telangiectasia (HHT) and cardiac failure is liver transplant. Anti-vascular endothelial growth factor treatments such as...
5.
Dupuis-Girod S, Chesnais A, Ginon I, Dumortier J, Saurin J, Finet G, et al.
Liver Transpl
. 2010 Mar;
16(3):340-7.
PMID: 20209594
Hepatic involvement occurs in up to 74% of patients with hereditary hemorrhagic telangiectasia (HHT) and is characterized by a spectrum of arteriovenous malformations. Three different types of intrahepatic shunting may...
6.
Rioufol G, Gilard M, Finet G, Ginon I, Boschat J, Andre-Fouet X
Circulation
. 2004 Oct;
110(18):2875-80.
PMID: 15492303
Background: Ruptured coronary atheromatous plaque is generally considered to involve a high risk of subsequent clinical events. Few data are available on the natural evolution of non-culprit-lesion ruptured plaque. We...
7.
Andre-Fouet X, Ginon I, Thivolet S
Rev Prat
. 2002 Nov;
52(15):1644-9.
PMID: 12434592
Most of patients with heart failure present a left ventricular systolic dysfunction usually, if not always, associated with a diastolic dysfunction. Clinical manifestations and physical examination allows a presumed diagnosis....